{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"139"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"150"}],"units":"Participants"}],"description":"The primary objective of this study was to demonstrate the efficacy of QST (QuickShot Testosterone) administered subcutaneously once each week to adult males with hypogonadism.","groups":[{"description":"Testosterone enanthate 50 mg / 75 mg / 100 mg administered subcutaneously once each week with possible titration to a higher or lower dose at scheduled intervals during study.","id":"OG000","title":"Testosterone Enanthate Auto-injector"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"The Population consisted of all patients who received at least 1 dose of the investigational product. Percentage was calculated using the number of patients in the column heading as the denominator.","reportingStatus":"POSTED","timeFrame":"12 weeks","title":"Percentage of Patients With Total Testosterone Cavg(0-168h) Serum Concentrations Within the Normal Range (300-1100 ng/dL)","type":"PRIMARY","unitOfMeasure":"Participants"}